S-Oil (KRX 010950) 2026 stock outlook. A deep qualitative look at the refining margin (crack spread) cycle, Saudi Aramco parent synergy, the Shaheen petrochemical downstream expansion, the high-dividend policy, oil-price and currency sensitivity, and the key investment risks for global investors.
Samsung Life Insurance 032830 stock outlook 2026 for global investors. We break down its strategically critical Samsung Electronics stake, K-ICS solvency, IFRS17 dynamics, dividend and shareholder-return story, Insurance Business Act stake-valuation and interest-rate risks, and value-up upside.
Philips Respironics CPAP, BiPAP and ventilator recall lawsuit 2026 — the 2021 Class I recall, degrading PE-PUR foam and cancer concerns, how the personal injury MDL differs from the economic loss and medical monitoring class settlements, eligibility, proof, fees, and the statute of limitations for U.S. claimants.
A clear 2026 guide to the Tepezza (teprotumumab) hearing loss and tinnitus lawsuit for U.S. plaintiffs. Learn the failure-to-warn theory against Horizon Therapeutics (now Amgen), MDL status, eligibility based on infusions and audiograms, proof elements, settlement tiers, contingency fees, and the statute of limitations.
Injured working at sea? The Jones Act — not state workers' comp — protects seamen. Learn who qualifies as a seaman, how negligence and unseaworthiness claims work, your maintenance and cure rights, the 3-year deadline, and how maritime attorneys charge.
Koh Young Technology (098460) 2026 stock outlook. A qualitative deep dive into its global No. 1 position in 3D SPI/AOI inspection equipment, SMT inspection market share, the Meister semiconductor-packaging inspection growth lever, the KYMERO brain-surgery medical robot option value, electronics and automotive demand, FX and cyclical sensitivity, the R&D moat, valuation, and what a U.S.-based investor should watch.
A 2026 guide to the NEC baby formula lawsuit: who qualifies after a premature infant developed necrotizing enterocolitis on cow's-milk-based Similac or Enfamil, the NICU medical records you need to prove it, MDL 3026 and Illinois state-court status, settlement and contingency-fee structure, and statute-of-limitations basics for U.S. plaintiffs.
A 2026 stock outlook for NH Investment & Securities (KRX 005940), analyzing the NongHyup-affiliated broker's IB franchise (ECM, DCM, real estate), high-dividend policy, WM and retail brokerage, bond and trading P&L, real-estate PF exposure risk, the rate cycle, and the Korean value-up re-rating thesis.
A plain-English 2026 guide to the Ozempic, Wegovy and Mounjaro stomach paralysis (gastroparesis) and bowel obstruction lawsuits. Learn who may qualify, how MDL 3094 consolidation works, what you must prove, settlement and contingency-fee structure, and the statute of limitations.
F&F (KRX 383220) stock outlook 2026: how the MLB and Discovery Expedition brands, China revenue exposure and consumer-slowdown risk, the licensed-brand profit model, the F&F Holdings structure, high-margin cash generation, FX and dividends shape the case for global investors.
Park Systems (KRX 140860) stock outlook 2026 for global investors: the atomic force microscope (AFM) moat, semiconductor metrology demand from node shrink, industrial vs. research markets, the Accurion acquisition adding Raman and thin-film metrology, capex sensitivity, plus a hard look at the stretched valuation and currency risk.
An EO Technics (039030) stock outlook for 2026 covering its laser marking, drilling, grooving and annealing equipment, semiconductor back-end and advanced packaging demand, the glass substrate opportunity, Samsung as a customer, the capex cycle, FX, valuation, and what global investors should track each quarter.
An English-language 2026 outlook on HDC Hyundai Development (KRX 294870): its developer (self-development) profit model, the brand and safety recovery after the 2022 Gwangju Hwajeong collapse, real-estate project-finance and unsold-inventory risk, the pre-sale and construction cycle, rate sensitivity, the Yongsan complex-development option, and dividends — written for global investors.
A 2026 stock outlook for Jusung Engineering (KRX 036930), covering its semiconductor ALD (atomic layer deposition) equipment franchise, memory capex sensitivity to SK hynix and Samsung, DRAM/HBM and high-k tool demand, display and solar volatility, patent moat, and the sharp cyclicality of an equipment maker. Includes how foreign investors should think about KRW exposure and taxes.
A 2026 stock outlook for Hanwha Life (KRX: 088350), one of Korea's life-insurance Big 3, covering the IFRS17 transition and CSM, protection-policy mix, interest-rate sensitivity and asset-liability duration, the K-ICS solvency ratio, the Hanwha Life Financial Services GA channel, dividend resumption odds, demographic risk, and value-up tailwinds for global investors.
A 2026 outlook on Samsung Securities (KRX 016360): its wealth management and ultra-high-net-worth SNI franchise, retail overseas equity brokerage, top-tier dividend payout among Korean brokers, trading-volume cyclicality, low real-estate PF exposure, and the value-up re-rating case for foreign investors.
A 2026 outlook on DB Insurance (KRX 005830), one of Korea's top P&C insurers, framed around its auto, long-term health and general insurance mix, IFRS17 CSM accumulation and earnings recognition, loss ratio and combined ratio, K-ICS capital, high-dividend and buyback shareholder returns, US and Southeast Asia operations, and the Korean insurer value-up theme.
A practical 2026 guide to Directors & Officers liability insurance for US businesses: what D&O covers, who needs it (public companies, VC-backed startups, nonprofit boards), Side A/B/C coverage structure, premium cost ranges, limits and retentions, claim examples, EPLI overlap, exclusions, and a buyer's checklist.
A cautious Hanssem (009240) 2026 outlook covering its furniture and remodeling moat, Rehaus and kitchen/bath revenue model, sensitivity to Korean housing transactions, IMM PE ownership, dividends, and the turnaround leverage thesis for global investors.
A clear-eyed Hyundai Marine & Fire Insurance (KRX 001450) stock outlook for 2026: Korea's big-four P&C franchise, auto/long-term/general lines, IFRS 17 CSM and actuarial-assumption sensitivity, K-ICS capital, and dividend policy explained for global investors.
A 2026 stock outlook for Hyundai Wia (KRX: 011210) written for global and US-based investors. We break down its auto-parts business (engines, CV joints, 4WD, integrated thermal modules), machine tools, defense work, the electrification opportunity and risk, Hyundai/Kia sales dependency, valuation, dividends, and group-concentration risk.
An analysis of ISC (KRX 095340) stock outlook for 2026, covering its silicone rubber and pogo test sockets, exposure to AI/HBM and high-performance chip test demand, the governance shift after SKC acquired control, customer diversification, semiconductor-cycle sensitivity, and valuation. Includes a tax and currency angle for international and U.S.-based investors.
KCC Corporation (KRX:002380) 2026 stock outlook. We analyze the Momentive silicones acquisition and cycle, the paints and building-materials portfolio, listed equity holdings such as Samsung C&T, NAV, debt load, dividends, and the asset-value undervaluation debate.
Kiwoom Securities (039490) stock outlook 2026: how Korea's No.1 retail brokerage by trading value defends its Hero MTS moat against Toss and KakaoPay Securities, why earnings hinge on turnover, plus overseas-trading growth, margin-loan interest income, mega-IB licensing, and dividends.